Ha, good questions and observations about Pestell. I agree it didn't seem to go well the first time around with him at Cytodyn. I thought maybe they had patched things up, but not sure really.

https://www.cytodyn.com/newsroom/press-releas...ith-former

Quote:

---

Dr. Pestell and the Company are also exploring ways in which Dr. Pestell can reengage with the Company to help realize leronlimab’s full potential in oncology.

---

I really don't know his current role, just speculating about why cancer is back on the table for trials, and why CRC versus TNBC, GBM, prostate, or other cancer.